AKT1 and neoplasm: Experimental studies corroborated by clinical evidence point to deregulated AKT kinase activity as being causally linked to oncogenic transformation and tumor growth, thus providing the impetus for understanding the regulation of AKT as a critical target for the management and therapy of malignant diseases.